Concordance of adolescent human papillomavirus vaccination parental report with provider report in the National Immunization Survey-Teen (2008–2013)

Vaccine

Volumn 34, Issue 37, 2016, Pages 4415-4421

  Hirth, Jacqueline ^a   Kuo, Yong Fang ^a   Laz, Tabassum Haque ^a,b   Starkey, Jonathan M ^c   Rupp, Richard E ^a   Rahman, Mahbubur ^a,d   Berenson, Abbey B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Health Research and Consulting Services   (Bangladesh)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d ST LUKE'S INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Accuracy of vaccine reporting; Human papillomavirus vaccine; Parental HPV vaccine report

Indexed keywords

WART VIRUS VACCINE;

ACCURACY; ADOLESCENT; AGE; ARTICLE; BLACK PERSON; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HISPANIC; HUMAN; INCOME; MAJOR CLINICAL STUDY; MINORITY GROUP; PAPILLOMAVIRUS INFECTION; PARENT; PRIORITY JOURNAL; RACE DIFFERENCE; SELF REPORT; TIME; VACCINATION; AFRICAN AMERICAN; MEASUREMENT ACCURACY; PAPILLOMAVIRUS INFECTIONS; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AFRICAN AMERICANS; DATA ACCURACY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; SENSITIVITY AND SPECIFICITY; SURVEYS AND QUESTIONNAIRES; VACCINATION;

EID: 84990929559     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.07.014     Document Type: Article

References (24)

1. [1] Hofstetter, A.M., Ompad, D.C., Stockwell, M.S., Rosenthal, S.L., Soren, K., Human papillomavirus vaccination and cervical cytology outcomes among urban low-income minority females. JAMA Pediatr, 2016 epub.
2. [2] Hariri, S., Bennett, N.M., Niccolai, L.M., et al. Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States-2008–2012. Vaccine 33:12 (2015), 1608–1613.
3. [3] Bogaards, J.A., Coupé, V.M.H., Xiridou, M., Miejer, C.J.L.M., Wallinga, J., Berkhof, J., Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence. Epidemiology 22 (2011), 505–515.
4. [4] FUTURE I/II Study Group, Dillner, J., Kjaer, S.K., et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ, 341, 2010, c3493, 10.1136/bmj.c3493.
5. [5] FUTURE II Study Group, Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 369 (2007), 1861–1868.
6. [6] Petrosky, E., Bocchini, J.A., Hariri, S., et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR 64:11 (2015), 300–304.
7. [7] Reagan-Steiner, S., Yankey, D., Jeyarajah, J., et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years – United States, 2014. MMWR 64:29 (2015), 784–792.
8. [8] Centers for Disease Control and Prevention. Behavioral risk factor surveillance system. < http://www.cdc.gov/brfss>.
9. [9] Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. In: Statistics NCfH, ed. < http://www.cdc.gov/nchs/nhanes>.
10. [10] Centers for Disease Control and Prevention. National Health Interview Survey. < http://www.cdc.gov/nchs/nhis>.
11. [11] Dunne, E.F., Markowitz, L.E., Chesson, H., et al. Recommendations on the use of quadrivalent human papillomavirus vaccine in males – advisory committee on immunization practices (ACIP), 2011. MMWR 60:50 (2011), 1705–1708.
12. [12] U.S. Department of Health and Human Services (DHHS). Datasets for the National Immunization Survey – Teen. In: Hyattsville MD, editor. National center for health statistics, centers for disease control and prevention. < http://www.cdc.gov/nchs/nis>.
13. [13] Jane, N., Singleton, J.A., Montgomery, M., Skalland, B., Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006. Public Health Rep 124 (2009), 642–651.
14. [14] Dorell, C.G., Jain, N., Yankey, D., Validity of parent-reported vaccination status for adolescents aged 13–17 years: National Immunization Survey-Teen, 2008. Public Health Rep 126 (2011), 60–69.
15. [15] Rolnick, S.J., Parker, E.D., Nordin, J.D., et al. Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?. Vaccine 31 (2013), 3928–3935.
16. [16] Ojha, R.P., Tota, J.E., Offutt-Powell, T.N., Klosky, J.L., Ashokkumar, R., Gurney, J.G., The accuracy of human papillomavirus vaccination status based on adult proxy recall or household immunization records for adolescent females in the United States: results from the National Immunization Survey-Teen. Ann Epidemiol 23 (2013), 281–285.
17. [17] Lu, P.-J., Dorell, C.G., Yankey, D., Santibanez, T.A., Singleton, J.A., A comparison of parent and provider reported influenza vaccination status of adolescents. Vaccine 30 (2012), 3278–3285.
18. [18] Hirth, J.M., Tan, A., Wilkinson, G.S., Berenson, A.B., Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer 118 (2012), 5623–5629.
19. [19] Apte, G., Pierre-Joseph, N., Vercruysse, J.L., Perkins, R.B., Could poor parental recall of HPV vaccination contribute to low vaccination rates?. Clin Pediatr 54:10 (2015), 987–991.
20. [20] Jackson, M.L., Henrikson, N.B., Grossman, D.C., Evaluating Washington State's immunization information system as a research tool. Acad Pediatr 14:1 (2013), 71–76.
21. [21] Stecher, D.S., Adelman, R., Brinkman, T., Bulloch, B., Accuracy of a stat immunization registry in the pediatric emergency department. Pediatr Emerg Care 24:2 (2008), 71–74.
22. [22] Holman, D.M., Benard, V., Roland, K.B., Watson, M., Liddon, N., Stokley, S., Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr 168:1 (2014), 76–82.
23. [23] Yang, D.X., Soulos, P.R., Davis, B., Gross, C.P., Yu, J.B., Impact of widespread cervical cancer screening: number of cancers prevented and changes in race-specific incidence. Am J Clin Oncol, 2016, 1–6 epub.
24. [24] Yin, D., Morris, C., Allen, M., Cress, R., Bates, J., Liu, L., Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?. Cancer Causes Control 21:10 (2010), 1721–1730.